Acute alveolitis induced by hydroxyurea in a patient with myeloproliferative syndrome.
Hydroxyurea is increasingly being used to control myeloproliferative disorders, in part because of its relative lack of side effects. We present a case of life-threatening alveolitis in a patient treated with hydroxyurea for myeloproliferative syndrome. Absence of exposure to other drugs and the clinical course suggest that the alveolitis was induced by hydroxyurea.
Hennemann
B
B
Department of Internal Medicine I, University of Regensburg, Germany.
Bross
K J
KJ
Reichle
A
A
Andreesen
R
R
D000208:Acute Disease; D000368:Aged; D000542:Alveolitis, Extrinsic Allergic / Q000139:chemically induced*; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects* / Q000627:therapeutic use*; D008297:Male; D009196:Myeloproliferative Disorders / Q000188:drug therapy*; D011014:Pneumonia / Q000139:chemically induced; D011650:Pulmonary Alveoli
D006918:Hydroxyurea